<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Hematol</journal-id>
      <journal-title-group>
        <journal-title>Annals of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0939-5555</issn>
      <issn pub-type="epub">1432-0584</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21584668</article-id>
      <article-id pub-id-type="pmc">3254866</article-id>
      <article-id pub-id-type="publisher-id">1257</article-id>
      <article-id pub-id-type="doi">10.1007/s00277-011-1257-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>F-18 Fluorodeoxyglucose non-avid hepatosplenic T cell lymphoma: a diagnostic pitfall</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ho</surname>
            <given-names>Siu-Lun</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loong</surname>
            <given-names>Florence</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lam</surname>
            <given-names>Clarence</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anthony</surname>
            <given-names>Marina-Portia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kwong</surname>
            <given-names>Yok-Lam</given-names>
          </name>
          <address>
            <phone>+86-852-22555859</phone>
            <fax>+86-852-29741165</fax>
            <email>ylkwong@hkucc.hku.hk</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Pathology, Queen Mary Hospital, Hong Kong, China </aff>
        <aff id="Aff2"><label>2</label>Department of Diagnostic Radiology, Queen Mary Hospital, Hong Kong, China </aff>
        <aff id="Aff3"><label>3</label>Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>17</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2012</year>
      </pub-date>
      <volume>91</volume>
      <issue>2</issue>
      <fpage>307</fpage>
      <lpage>308</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2012</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>A 59-year-old man presented with a 9-month history of transfusion-dependent anaemia, hepatomegaly (2&#xA0;cm) and splenomegaly (6&#xA0;cm). F-18 fluorodeoxyglucose (FDG) positron emission tomography computed tomography (PET/CT) showed gross hepatosplenomegaly (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>) that was eumetabolic (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>), raising the possibility that the cause might be non-neoplastic. However, bone marrow examination showed a small population of suspicious T cells with no clear histopathological patterns. The T cell receptor (TCR) gamma gene was clonally rearranged on polymerase chain reaction, suggesting that the hepatosplenomegaly might be related to a clonal T cell neoplasm.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>A case of hepatosplenic T cell lymphoma with negative positron emission tomography. <bold>a</bold> Computed tomography of the abdomen, showing gross hepatosplenomegaly. <bold>b</bold> Positron emission tomography showing that the hepatosplenomegaly was eumetabolic. <bold>c</bold> The spleen showed red pulp infiltration by atypical lymphoid cells. <bold>d</bold> The liver showed infiltration of sinusoids (<italic>arrows</italic>) by atypical lymphoid cells. <bold>e</bold>&#x2013;<bold>h</bold> Immunoperoxidase staining, showing that the lymphoma cells were positive for CD3 (<bold>e</bold>), negative for CD4 and CD8 (<bold>f</bold>, <bold>g</bold>), and positive for TCR&#x3B3; (<bold>h</bold>)</p></caption><graphic xlink:href="277_2011_1257_Fig1_HTML" id="MO1"/></fig></p>
    <p>Splenectomy and liver biopsy were performed. Histologically, there was cord expansion and sinusoidal infiltration in the splenic red pulp by small atypical lymphoid cells (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>). These neoplastic lymphoid cells were also found as small aggregates in the hepatic sinusoids (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). On immunophenotyping, the lymphoid cells were CD3+, CD4&#x2212;, CD8&#x2212;, TIA-1+, TCR&#x3B2;&#x2212; and TCR&#x3B3;+ (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e&#x2013;h</xref>). The overall features were consistent with hepatosplenic T cell lymphoma (HSTCL) of the &#x3B3;&#x3B4; subtype.</p>
    <p>PET/CT is used extensively in the staging and post-treatment follow-up of Hodgkin's lymphoma, where it is considered a standard of care [<xref ref-type="bibr" rid="CR1">1</xref>]. It is also regarded as highly sensitive in most aggressive and indolent B cell lymphomas [<xref ref-type="bibr" rid="CR2">2</xref>]. FDG uptake is usually proportional to histopathological grading, being very avid in high-grade lymphomas that are metabolically active. Although this pattern is generally observed in B cell lymphomas, it is undefined if FDG uptake also parallels the clinical behaviour in T cell lymphomas. In fact, PET/CT has been reported to be negative in some T cell malignancies, notably T-large granular lymphocyte leukaemia and T-prolymphocytic leukaemia [<xref ref-type="bibr" rid="CR3">3</xref>]. HSTCL is an aggressive lymphoma with a poor survival. It accounts for less than 1% of all lymphomas. Because HSTCL is rare, the application of PET/CT in its diagnosis and management has not been evaluated. FDG avidity had only been previously reported in a single case of HSTCL occurring after liver transplantation [<xref ref-type="bibr" rid="CR4">4</xref>]. Our case apparently had arisen de novo. The lymphoma was entirely FDG non-avid, constituting a diagnostic pitfall. Therefore, the role of PET/CT in the diagnosis and follow-up of T cell lymphomas may have to be carefully defined for each histopathological type [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
  </body>
  <back>
    <ack>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gallamini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hutchings</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rigacci</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Specht</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Merli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Patti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Loft</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Raimondo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>D'Amore</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Biggi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vitolo</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Stelitano</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sancetta</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Trentin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Luminari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iannitto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Viviani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pierri</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Levis</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study</article-title>
          <source>J Clin Oncol</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>3746</fpage>
          <lpage>3752</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.11.6525</pub-id>
          <pub-id pub-id-type="pmid">17646666</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juweid</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Stroobants</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hoekstra</surname>
              <given-names>OS</given-names>
            </name>
            <name>
              <surname>Mottaghy</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Dietlein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Guermazi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wiseman</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Kostakoglu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Scheidhauer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Buck</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Naumann</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Spaepen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hicks</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Reske</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Schwaiger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Zijlstra</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
          <article-title>Imaging Subcommittee of International Harmonization Project in Lymphoma. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma</article-title>
          <source>J Clin Oncol</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>571</fpage>
          <lpage>578</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2006.08.2305</pub-id>
          <pub-id pub-id-type="pmid">17242397</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khong</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kwong</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Au</surname>
              <given-names>WY</given-names>
            </name>
          </person-group>
          <article-title>Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies</article-title>
          <source>Ann Hematol</source>
          <year>2008</year>
          <volume>87</volume>
          <fpage>613</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="doi">10.1007/s00277-008-0494-8</pub-id>
          <pub-id pub-id-type="pmid">18509641</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roelandt</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Maertens</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vandenberghe</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Verslype</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roskams</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Aerts</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nevens</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dierickx</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature</article-title>
          <source>Liver Transpl</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>686</fpage>
          <lpage>692</lpage>
          <pub-id pub-id-type="doi">10.1002/lt.21748</pub-id>
          <pub-id pub-id-type="pmid">19562701</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29:1844&#x2013;1854</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
